Cancer Research

A Single Dose for Good Measure: How an Anti-Nuclear-Contamination Pill Could Also Help MRI Patients

September 12, 2019

Rebecca Abergel

When chemist Rebecca Abergel (Ph.D. '06, Chem) and her team at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory successfully developed an anti-radiation-poisoning pill in 2014, they hoped it would never have to be used. Now the researchers are studying how that very same pill could help protect people from the potential toxicity of something else – the long-term retention of gadolinium, a critical ingredient in widely used contrast dyes for MRI (magnetic resonance imaging) scans.

Frontier Medicines launches $67M startup to develop novel medicines that target "undruggable" diseases

June 26, 2019

Frontier Medicines launches new company to fight cancerFrontier Medicines has announced the launch of a new startup to actively develop medical treatments for currently "undruggable" diseases. According to the American Cancer Society, approximately 1,762,000 new cancer cases and approximately 607,000 deaths from cancer are expected to occur in the US in 2019.

Harnessing the cellular “trash can” to fight cancer

June 18, 2019

Fighting cancerUC Berkeley scientists have published a new study in Nature Chemical Biology that investigates how nimbolide, a natural product derived from the neem tree, may function in impairing cancer pathogenicity.

College alum launches another successful biotech startup

August 29, 2016

Terry Rosen giving 2016 Commencement AddressTerry Rosen—alum, donor, commencement speaker and serial biotech entrepreneur—has launched another successful start up.

Drug sponge could minimize side effects of cancer treatment

January 9, 2019

scientists discover new drug spongeWith the help of sponges inserted in the bloodstream to absorb excess drugs, doctors and scientists are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don’t respond to more benign treatments.

Jnana Therapeutics announces appointment of alum Joanne Kotz, Ph.D. as Chief Executive Officer

November 6, 2018

Joanne Kotze, PhD, Jnana TherapeuticsJnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017. For more information...

Smallest life forms have smallest working CRISPR system

October 18, 2018

Archaea bacteria with CRISPR systems.

An ancient group of microbes that contains some of the smallest life forms on Earth also has the smallest CRISPR gene-editing machinery discovered to date.

Five distinguished individuals to be honored with highest American Cancer Society Award

October 17, 2018

American Cancer Society LogoThe American Cancer Society will bestow its highest honor – the Medal of Honor – to five individuals on Oct. 18 in Washington DC. The Medal of Honor is awarded to distinguished individuals who have made valuable contributions in the fight against cancer. The 2018 recipients include the Honorable Joseph R. Biden Jr., for Cancer Control; Emmanuelle Charpentier, PhD, for Basic Research; Jennifer Doudna, PhD, for Basic Research; Charis Eng, MD, PhD, for Clinical Research; and Michael J. Thun MD, MS, for Cancer Control Science.

Doudna joins Biden during Bay Area stop on cancer ‘listening tour’

February 29, 2016

Jennifer DoudnaWhen Vice President Joe Biden dropped by UC San Francisco on Saturday for a wide-ranging discussion of the current state of cancer research, UC Berkeley’s Jennifer Doudna was on hand to emphasize the need to fund basic research as well as clinical research.